These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 22864123

  • 1. Agranulocytosis immediately after oral administration of cibenzoline and dabigatran in a patient with paroxysmal atrial fibrillation.
    Hayashi H, Kitoh K, Mitsunami K, Horie M.
    Intern Med; 2012; 51(15):1987-90. PubMed ID: 22864123
    [Abstract] [Full Text] [Related]

  • 2. Dabigatran-induced acute hepatitis.
    Rochwerg B, Xenodemetropoulos T, Crowther M, Spyropoulos A.
    Clin Appl Thromb Hemost; 2012 Sep; 18(5):549-50. PubMed ID: 22962308
    [No Abstract] [Full Text] [Related]

  • 3. Dabigatran overdose secondary to acute kidney injury and amiodarone use.
    Fountzilas C, George J, Levine R.
    N Z Med J; 2013 Mar 01; 126(1370):110-2. PubMed ID: 23474519
    [Abstract] [Full Text] [Related]

  • 4. Gastrointestinal bleeding under dabigatran.
    Stöllberger C, Lindner K, Finsterer J.
    J Postgrad Med; 2014 Mar 01; 60(2):192-3. PubMed ID: 24823522
    [Abstract] [Full Text] [Related]

  • 5. [New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].
    Koziński M, Obońska K, Kubica A, Navarese EP, Kubica J.
    Kardiol Pol; 2012 Mar 01; 70(10):1053-60. PubMed ID: 23080100
    [No Abstract] [Full Text] [Related]

  • 6. [Comparison of three methods of antithrombotic therapy in elderly patients with nonvalvular atrial fibrillation].
    Shevelev VI, Kanorskiĭ SG.
    Kardiologiia; 2012 Mar 01; 52(7):56-60. PubMed ID: 22839715
    [Abstract] [Full Text] [Related]

  • 7. Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.
    Eikelboom JW, Connolly SJ, Hart RG, Wallentin L, Reilly P, Oldgren J, Yang S, Yusuf S.
    J Am Coll Cardiol; 2013 Sep 03; 62(10):900-8. PubMed ID: 23770182
    [Abstract] [Full Text] [Related]

  • 8. Modeling of the impact on health outcomes of the use of dabigatran in patients with atrial fibrillation.
    Chevalier J, Giroud M, de Pouvourville G.
    Cerebrovasc Dis; 2013 Sep 03; 35(4):320-6. PubMed ID: 23615428
    [Abstract] [Full Text] [Related]

  • 9. New era of oral anticoagulation for Japanese non-valvular atrial fibrillation patients.
    Hirano T.
    Circ J; 2014 Sep 03; 78(6):1317-9. PubMed ID: 24805358
    [No Abstract] [Full Text] [Related]

  • 10. Reversing dabigatran in life-threatening bleeding occurring during cardiac ablation with factor eight inhibitor bypassing activity.
    Dager WE, Gosselin RC, Roberts AJ.
    Crit Care Med; 2013 May 03; 41(5):e42-6. PubMed ID: 23474679
    [Abstract] [Full Text] [Related]

  • 11. New evidences for old concerns with oral anticoagulation in atrial fibrillation: focus on dabigatran.
    Barrios V, Escobar C.
    Expert Opin Pharmacother; 2012 Dec 03; 13(18):2649-61. PubMed ID: 23167273
    [Abstract] [Full Text] [Related]

  • 12. Left atrial appendage thrombus with resulting stroke post-RF ablation for atrial fibrillation in a patient on dabigatran.
    Lobo R, McCann C, Hussaini A, Meany TB, Kiernan TJ.
    Ir Med J; 2014 Dec 03; 107(10):329-30. PubMed ID: 25551903
    [Abstract] [Full Text] [Related]

  • 13. Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature.
    Fasullo S, Davì S, Cosenza G, Di Franco F, La Manna N, Giubilato A, Vetrano G, Maringhini G.
    J Thromb Thrombolysis; 2018 May 03; 45(4):588-592. PubMed ID: 29404875
    [Abstract] [Full Text] [Related]

  • 14. Intracranial hemorrhage during dabigatran treatment.
    Komori M, Yasaka M, Kokuba K, Matsuoka H, Fujimoto S, Yoshida M, Kameda K, Shono T, Nagata S, Ago T, Kitazono T, Okada Y.
    Circ J; 2014 May 03; 78(6):1335-41. PubMed ID: 24662438
    [Abstract] [Full Text] [Related]

  • 15. The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study.
    Connolly SJ, Wallentin L, Ezekowitz MD, Eikelboom J, Oldgren J, Reilly PA, Brueckmann M, Pogue J, Alings M, Amerena JV, Avezum A, Baumgartner I, Budaj AJ, Chen JH, Dans AL, Darius H, Di Pasquale G, Ferreira J, Flaker GC, Flather MD, Franzosi MG, Golitsyn SP, Halon DA, Heidbuchel H, Hohnloser SH, Huber K, Jansky P, Kamensky G, Keltai M, Kim SS, Lau CP, Le Heuzey JY, Lewis BS, Liu L, Nanas J, Omar R, Pais P, Pedersen KE, Piegas LS, Raev D, Smith PJ, Talajic M, Tan RS, Tanomsup S, Toivonen L, Vinereanu D, Xavier D, Zhu J, Wang SQ, Duffy CO, Themeles E, Yusuf S.
    Circulation; 2013 Jul 16; 128(3):237-43. PubMed ID: 23770747
    [Abstract] [Full Text] [Related]

  • 16. The untold story of Dabigatran etexilate: alveolar hemorrhage in an elderly patient with interstitial pulmonary fibrosis.
    Husari A, Beydoun A, Sheik Ammar A, Maakaron JE, Taher A.
    J Thromb Thrombolysis; 2013 Jan 16; 35(1):81-2. PubMed ID: 22843168
    [Abstract] [Full Text] [Related]

  • 17. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
    Brunetti L, Chen C, White J.
    Consult Pharm; 2014 Mar 16; 29(3):169-78. PubMed ID: 24589766
    [Abstract] [Full Text] [Related]

  • 18. Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
    Fieland D, Taylor M.
    Ann Pharmacother; 2012 Jan 16; 46(1):e3. PubMed ID: 22202498
    [Abstract] [Full Text] [Related]

  • 19. New oral anticoagulants in atrial fibrillation forever?
    Verheugt FW.
    Circulation; 2013 Jul 16; 128(3):200-2. PubMed ID: 23770746
    [No Abstract] [Full Text] [Related]

  • 20. Dabigatran for stroke prevention in atrial fibrillation.
    Hohnloser SH, Diener HC.
    Hamostaseologie; 2012 Jul 16; 32(3):216-20. PubMed ID: 22739760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.